A powerful tool for cancer

A cancer diagnosis is stressful and overwhelming. We’re here to help.

Understanding your genes can help guide you and your doctor to the most effective treatments, bringing you one step closer to beating cancer and then staying healthy in the long term.

Genetic testing and cancer

Half of all men and one-third of all women in the US will develop cancer during their lifetimes.1

In many cases, a person’s genetics has made them more susceptible to cancer—and, as a result, they may respond differently to therapies, benefit from more aggressive treatment, or take action to avoid getting cancer again in the future.

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

Download [1.64 MB]

1 in 8 patients

with cancer has a gene mutation passed down through their family

One-third of patients with high-risk mutations could benefit from different, more tailored cancer treatment after genetic testing. 2

How testing works

We know you’re getting a lot of tests right now. Our genetic tests can be started from the comfort of your home with a simple saliva sample.

Step 1

Request a test online. A doctor will place an order for you.

Step 2

Provide a saliva sample from the comfort of home.

Step 3

Get your results online and share them with your doctor. If you’d like, talk to a genetic counselor at no extra cost.

Find the right test

Be smart offers 3 tests that can tell you if you have a higher risk of developing cancer, heart disease, and other chronic conditions.

Ready to get started?


1.Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD. Accessed December 7, 2020. https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developing-or-dying-from-cancer.html/references, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Revised January 13, 2020.

2.Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. Published online October 30, 2020. doi:10.1001/jamaoncol.2020.6252